stella
beta
Disitamab Vedotin + Pyrotinib Versus THP in the First-line Treatment for HER2+ Advanced Breast Cancer Clinical Trial — Stella
Recruiting
Back to HER2-positive Metastatic Breast Cancer trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Sun Yat-sen Memorial Hospital,Sun Yat-sen University, Guangzhou, Guangdong
View full record on ClinicalTrials.gov